您当前的位置：
首页 >
文章列表页 >
Advances and perspectives in lactate-driven immunometabolic reprogramming for head and neck squamous cell carcinoma
更新时间：2026-04-08

    • Advances and perspectives in lactate-driven immunometabolic reprogramming for head and neck squamous cell carcinoma

    • Chin Oncol   Vol. 36, Issue 2, Pages: 180-189(2026)

    • DOI：10.19401/j.cnki.1007-3639.2026.02.010    

      CLC： R739.91

    • Received：08 August 2025，

      Revised：2026-01-04，

      Published：28 February 2026

    移动端阅览

  • XIAO Q T, YU J, WANG Y H, et al. Advances and perspectives in lactate-driven immunometabolic reprogramming for head and neck squamous cell carcinoma［J］. Chin Oncol, 2026, 36(2): 180-189. DOI： 10.19401/j.cnki.1007-3639.2026.02.010.

  •  
  •  

0

Views

111

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma
Progress and outlook of fundamental and translational breast cancer research in China, 2025
Progress and perspectives in the research on mechanisms of organ-specific metastasis in melanoma
New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2025
Mechanism study of MYC promoting proliferation and metastasis in prostate cancer by targeting CD47

Related Author

Shaoqiu ZHANG
Li YAN
Ruichen LI
Yang ZHAO
Xiaoshen WANG
Xuguang YANG
Yi ZHU
CHE Xiangxian

Related Institution

Clinical Research Center of Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Department of Radiation Oncology, Eye&ENT Hospital of Fudan University
Department of Breast Surgery, Fudan University Shanghai Cancer Center/Fudan University Breast Cancer Institute, Department of Oncology, Shanghai Medical College, Fudan University
Department of oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center
0